AGF Investments Inc. acquired a new position in shares of Evolent Health Inc (NYSE:EVH) in the third quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 125,000 shares of the technology company’s stock, valued at approximately $2,225,000. AGF Investments Inc. owned 0.18% of Evolent Health as of its most recent filing with the SEC.

Other large investors also recently bought and sold shares of the company. ETF Managers Group LLC purchased a new position in shares of Evolent Health during the 2nd quarter worth approximately $102,000. BNP Paribas Arbitrage SA boosted its position in shares of Evolent Health by 815.4% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 4,751 shares of the technology company’s stock worth $120,000 after purchasing an additional 4,232 shares during the period. First Mercantile Trust Co. purchased a new position in shares of Evolent Health during the 2nd quarter worth approximately $198,000. Royal Bank of Canada boosted its position in shares of Evolent Health by 1,197.8% during the 2nd quarter. Royal Bank of Canada now owns 8,293 shares of the technology company’s stock worth $210,000 after purchasing an additional 7,654 shares during the period. Finally, SG Americas Securities LLC purchased a new position in shares of Evolent Health during the 3rd quarter worth approximately $156,000. 95.38% of the stock is owned by hedge funds and other institutional investors.

Evolent Health Inc (NYSE:EVH) opened at $12.55 on Wednesday. The company has a debt-to-equity ratio of 0.11, a current ratio of 3.34 and a quick ratio of 3.34. Evolent Health Inc has a 1 year low of $10.30 and a 1 year high of $27.50.

Evolent Health (NYSE:EVH) last issued its quarterly earnings results on Thursday, November 2nd. The technology company reported ($0.04) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.08) by $0.04. Evolent Health had a negative net margin of 15.86% and a negative return on equity of 5.05%. The company had revenue of $107.90 million during the quarter, compared to analysts’ expectations of $104.49 million. During the same quarter last year, the company posted ($0.26) EPS. The firm’s revenue was up 79.2% compared to the same quarter last year. analysts forecast that Evolent Health Inc will post -0.57 EPS for the current fiscal year.

EVH has been the subject of a number of research analyst reports. SunTrust Banks reaffirmed a “buy” rating and set a $30.00 price objective on shares of Evolent Health in a research report on Friday, November 3rd. Jefferies Group reaffirmed a “buy” rating and set a $28.00 price objective on shares of Evolent Health in a research report on Wednesday, September 6th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $30.00 price objective on shares of Evolent Health in a research report on Thursday, November 2nd. Goldman Sachs Group cut shares of Evolent Health from a “conviction-buy” rating to a “buy” rating in a research report on Tuesday, November 7th. Finally, Zacks Investment Research raised shares of Evolent Health from a “sell” rating to a “hold” rating in a research report on Monday, October 9th. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and thirteen have issued a buy rating to the company. Evolent Health presently has a consensus rating of “Buy” and a consensus target price of $28.00.

TRADEMARK VIOLATION WARNING: “AGF Investments Inc. Invests $2.23 Million in Evolent Health Inc (EVH)” was reported by Daily Political and is the sole property of of Daily Political. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The legal version of this article can be read at https://www.dailypolitical.com/2017/11/29/agf-investments-inc-invests-2-23-million-in-evolent-health-inc-evh.html.

About Evolent Health

Evolent Health, Inc is engaged in healthcare delivery and payment. The Company supports health systems and physician organizations in their migration toward value-based care and population health management. The Company provides an end-to-end, technology-enabled services platform for providers. The Company’s platform, powered by its technology, processes and integrated services, enables providers to migrate their economic orientation from fee-for-service (FFS) reimbursement to payment models that reward value-based payment models.

Institutional Ownership by Quarter for Evolent Health (NYSE:EVH)

Receive News & Ratings for Evolent Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.